Maxcyte (MXCT) Inventory Average (2021 - 2025)
Historic Inventory Average for Maxcyte (MXCT) over the last 5 years, with Q3 2025 value amounting to $7.8 million.
- Maxcyte's Inventory Average fell 2787.68% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 2787.68%. This contributed to the annual value of $10.6 million for FY2024, which is 160.02% up from last year.
- Per Maxcyte's latest filing, its Inventory Average stood at $7.8 million for Q3 2025, which was down 2787.68% from $8.1 million recorded in Q2 2025.
- Over the past 5 years, Maxcyte's Inventory Average peaked at $12.4 million during Q4 2023, and registered a low of $4.2 million during Q3 2021.
- In the last 5 years, Maxcyte's Inventory Average had a median value of $8.6 million in 2025 and averaged $8.9 million.
- As far as peak fluctuations go, Maxcyte's Inventory Average skyrocketed by 8795.13% in 2022, and later plummeted by 2989.75% in 2025.
- Over the past 5 years, Maxcyte's Inventory Average (Quarter) stood at $4.7 million in 2021, then surged by 76.33% to $8.2 million in 2022, then skyrocketed by 50.14% to $12.4 million in 2023, then decreased by 22.03% to $9.7 million in 2024, then dropped by 19.49% to $7.8 million in 2025.
- Its last three reported values are $7.8 million in Q3 2025, $8.1 million for Q2 2025, and $8.6 million during Q1 2025.